News

Asure Software Achieves Major Milestone with $10.67 Stock High

Asure Software Achieves Major Milestone with $10.67 Stock High

Asure Software Reaches 52-Week High at $10.67

Asure Software Inc. (NASDAQ: ASUR) has made headlines as its stock soared to a remarkable 52-week high, currently priced at $10.67. This milestone is a significant achievement for the company, reflecting strong investor confidence and robust market conditions. Over the past year, Asure has shown remarkable resilience, with its stock witnessing an impressive 19.98% increase in value, a testament to its positive growth trajectory.

Strong Financial Performance and Market Position

The company boasts a gross profit margin of 68.55%, which highlights its efficient operations and profitability. However, technical indicators are raising flags, suggesting that the stock might be entering into overbought territory. Despite this, investors are increasingly optimistic about Asure's market standing and future growth prospects, which have driven the stock's remarkable ascent.

Recent Revenue Growth and Recurring Revenue Insights

Asure Software's recent financial disclosure for Q3 showcased a steady revenue of $29.3 million, bolstered by a notable 20% growth in recurring revenue. Impressively, recurring revenue now makes up 98% of total revenue, signifying a strong and stable income stream for the company. The past year's performance also included a robust 250% year-over-year growth in backlog, underscoring considerable potential for future expansion.

Strategic Acquisitions and Growth Initiatives

In its quest for growth, Asure Software has been very active in pursuing acquisitions, having completed 12 in the last year alone. These strategic moves have successfully added $15 million to its recurring revenue, further solidifying its position in the market. Asure's updated revenue guidance for 2024 is set between $119-$121 million, alongside an anticipated adjusted EBITDA margin of 18%-19%. Furthermore, preliminary guidance for 2025 suggests a potential revenue range of $134-$138 million, with an estimated EBITDA margin of 23%-24%.

Looking Ahead: New Solutions and Market Challenges

As part of its growth strategy, Asure Software plans to unveil AsurePay along with new solutions tailored for small businesses. This initiative aims to enhance their market offerings and expand their client base significantly. Despite encountering challenges such as workforce access issues for small businesses and potential interest rate impacts, the company maintains an optimistic outlook regarding its financial health.

Future Financial Strategies and Optimism

In light of its ambitious growth plans, Asure Software is contemplating debt financing in 2025 to support both organic and inorganic growth initiatives. These strategic shifts and considerations underscore Asure Software's commitment to navigating market complexities while also enhancing its future growth potential. With an active approach to both innovation and acquisition, Asure Software is poised for continued success in the tech landscape.

Frequently Asked Questions

What recent milestone did Asure Software achieve?

Asure Software reached a 52-week high stock price of $10.67.

What percentage increase did Asure Software's stock experience over the past year?

The company saw an impressive 19.98% increase in stock value over the past year.

How much did Asure Software's recurring revenue grow?

Recurring revenue grew by 20% and now comprises 98% of the company's total revenue.

How many acquisitions has Asure Software completed recently?

In the past year, Asure Software completed 12 acquisitions, contributing $15 million to recurring revenue.

What are Asure Software's revenue guidance expectations for 2024 and 2025?

The company expects revenue between $119-$121 million for 2024 and $134-$138 million for 2025.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 176

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 188

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 138

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 218

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 375

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 178

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 92

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
DIRECTV Bags New NHL Deals: Stakes for Sports Fans

Updated Category News Views 229

NHL Fans, Strap in: DIRECTV Expands Its Lineup In a world where keeping up with your favorite team gets tougher each day, DIRECTV just lobbed a puck right into the net with their latest play. They've snagged a multi-year deal with the NHL for the Carolina Hurricanes, Columbus Blue Jackets, Minnesota Wild, and St. Louis Blues networks. It's a game changer, folks. If you...

Continue Reading
ASTS Faces Crucial Deadline Amidst Legal Turmoil

Updated Category News Views 169

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

Pharma Equity Group's Journey Through H1 2025 Financials

Updated Category News Views 138

Pharma Equity Group's Interim Report for First Half of 2025 Key Highlights of H1 2025 Recently, Pharma Equity Group A/S underwent a thorough review by its Board of Directors and Executive Board, affirming their progress and strategies during the first half of 2025. Strategic Developments In a significant strategic shift, Pharma Equity Group has launched a new growth...

Continue Reading
Euro Manganese Welcomes New Director to Enhance Leadership Team

Updated Category News Views 110

Euro Manganese Inc. took a bold step back in 2024 when it brought on board Ms. Ludivine Wouters as a non-executive Director. This move was no ordinary appointment; it marked a significant shift in the company’s strategy as it aimed to solidify its presence in the battery materials sector, especially crucial for the electric vehicle (EV) industry. Strategic Shift: New...

Continue Reading
Gneuton Innovations: Revolutionizing Water Sustainability in AI

Updated Category News Views 333

Gneuton Innovations in AI Data Centers Gneuton, a groundbreaking clean technology company, is making waves in the field of regenerative AI infrastructure. The company has recently introduced a unique deployable water purification system that operates within gas turbine-powered AI data centers. This innovative system utilizes a patented thermal distillation technique,...

Continue Reading
Transamerica Reinforces Leadership for Retirement Expansion

Updated Category News Views 10

Transamerica's Next Phase: Leadership Moves in Retirement Transamerica just pulled a move that’s both bold and calculated. They’ve beefed up their retirement distribution squad with Danny Kling and Kevin Murphy stepping into the spotlight. These guys are bringing heaps of experience and a fresh jolt of energy to keep the momentum going. No doubt this is Transamerica...

Continue Reading
Unity Bancorp Drives Forward with Exciting Dividend Announcement

Updated Category News Views 129

Unity Bancorp Declares Cash Dividend for Shareholders Unity Bancorp, Inc. (NASDAQ: UNTY), the parent company of Unity Bank, has made an exciting announcement regarding its commitment to rewarding shareholders. The company's Board of Directors has declared a cash dividend amounting to $0.15 per common share. This dividend, representing a positive sign for shareholders,...

Continue Reading